KQ · Healthcare

Cell Biotech Co. Ltd (049960)

Biotechnology & Medical Research

Cell Biotech Co. Ltd (049960) is listed on KQ in the Healthcare sector. Industry: Biotechnology & Medical Research. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 049960

P/E ratio

25.00

Cell Biotech Co. Ltd (049960) — FAQ

What is 049960's P/E ratio?

The price-to-earnings (P/E) ratio for Cell Biotech Co. Ltd (049960) is 25.00 (data as of 2026-05-23).

Does Cell Biotech Co. Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Cell Biotech Co. Ltd (049960). Check the MyAverix Finance app for the latest dividend data.

What sector is Cell Biotech Co. Ltd in?

Cell Biotech Co. Ltd (049960) is classified in the Healthcare sector (Biotechnology & Medical Research industry).

What exchange is 049960 listed on?

049960 is listed on KQ.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)